Orasi Medical has developed Orasi Index, a technologically-advanced clinical development toolbox that provides pharmaceutical companies insight into the effect of drugs on brain function throughout the clinical development process. Orasi Index is comprised of three components: electrophysiology data, our innovative analytical engine, and the online reporting system, OrasiView™.

Electrophysiology
While fully supporting traditional EEG technology, the Orasi Index excels when applied to MEG. More advanced than EEG, MEG non-invasively measures magnetic fields generated by neuronal activity providing an accurate and objective evaluation of brain function.

Analytical Engine
The Orasi Index assesses both standard relative spectral power and functional connectivity using Orasi’s proprietary Synchronous Neural Interaction (SNI) Test™ to fully characterize patient response to CNS drugs. With the largest commercial database of MEG scans and clinical data, Orasi Index provides an expanding library of functional signatures specific for an array of CNS drugs and diseases.

OrasiView
Customers can access Orasi Index and their clinical trial results online using OrasiView. OrasiView is a web-based analysis and reporting tool that enables researchers to evaluate pharmacodynamics, drug mechanism, dose selection, and ongoing treatment effect, thereby supporting the critical decisions needed for successful CNS drug development.